antimicrobial resistance , AMR (Abkürzung)

Questions about antimicrobial resistance were not included in the survey.

There is only limited data available on antimicrobial resistance in most countries.

Control of antimicrobial resistance in the human health sector. 1.

The challenge of antimicrobial resistance clearly requires a new research focus.

What is the current status of the monitoring program on antimicrobial resistance? 10.

Antimicrobial resistance, already an Institute priority, is a global issue.

The government is to publish its antimicrobial resistance strategy next month.

"By working together in partnership, we can control the spread of antimicrobial resistance."

Antimicrobial resistance is an issue that affects both human and animal health.

To the knowledge of this committee, a risk assessment on antimicrobial resistance in Canada has not been done.

We must recognise, and respond to, the very serious threat of antimicrobial resistance.

Our ability to detect and monitor antimicrobial resistance is poor.

Our traditional response to the development of antimicrobial resistance is to use different, often new, drugs to treat the disease.

On the other hand, antimicrobial resistance is much more difficult to quantify and control.

Every year, 25 000 people die across Europe from causes associated with antimicrobial resistance.

Antibiotics are not used long-term due to the risk of antimicrobial resistance.

This dilemma is a central clinical problem in the field of antimicrobial resistance.

In this report, specific antimicrobial resistance patterns have been highlighted.

It is the basis for determining the causes of antimicrobial resistance.

What is antimicrobial resistance and why is it a key issue? 3.

Adverse effects of antimicrobial resistance from food animals on human health Chapter 3.

Conclusions The committee believes that antimicrobial resistance is an important problem for both human and animal health.

The global problem of advancing antimicrobial resistance has led to a renewed interest in its use recently.

Improve the transparency of risk assessment and management related to antimicrobial resistance.

Conclusions Major problems related to antimicrobial resistance exist in the human health sector.